The big deals with Novartis also allow GlaxoSmithKline to expand its vaccine business, GSK's CEO tells CNBC.
Some are calling Google's buying spree the ultimate sign of a bubble. But here's the key thing for investors to remember, says Michael Yoshikami.
Valeant and Bill Ackman are staging a $45 billion bid for botox maker Allergan.
Although estimates on Alibaba's worth vary widely, market analysts agree Alibaba Group's IPO will be a blockbuster—and that's good news for Yahoo.
Get the best of CNBC in your inbox